Bactericidal effects of triclosan in soap both in vitro and in vivo

S. A. Kim, H. Moon, K. Lee, Min-Suk Rhee

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

OBJECTIVES: On December 2013, the US FDA proposed a rule stating that manufacturers must provide data to demonstrate that antibacterial soap is more effective than plain soap or water. The objective of the present study was to examine the in vitro and in vivo bactericidal effect of triclosan (the most widely used antiseptic agent in soap) in soap.

METHODS: Twenty bacterial strains (proposed by the FDA) were exposed to plain and antibacterial soaps (the same formulation as plain soap, but containing 0.3% triclosan) for 20 s at 22°C (room temperature) and 40°C (warm temperature). The temperature and time were selected to simulate the hand washing conditions and procedures used by consumers. The triclosan concentration of 0.3% is the maximum allowed by law. The decontamination efficacy of plain soap and antibacterial soap was also examined in vivo: the hands of volunteers were artificially inoculated with Serratia marcescens.

RESULTS: There was no significant difference (P > 0.05) in bactericidal activity between plain soap and antibacterial soap at either test temperature. However, antibacterial soap showed significantly greater bactericidal effects after 9 h. These results suggest that although triclosan-containing soap does have antibacterial activity, the effects are not apparent during the short time required for hand washing.

CONCLUSIONS: Antibacterial soap containing triclosan (0.3%) was no more effective than plain soap at reducing bacterial contamination when used under 'real-life' conditions. The present study provides practical information that may prove useful for both industry and governments.

Original languageEnglish
Pages (from-to)3345-3352
Number of pages8
JournalJournal of Antimicrobial Chemotherapy
Volume70
Issue number12
DOIs
Publication statusPublished - 2015 Dec 1

Fingerprint

Triclosan
Soaps
Hand Disinfection
Temperature
In Vitro Techniques
Serratia marcescens
Local Anti-Infective Agents
Decontamination

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Bactericidal effects of triclosan in soap both in vitro and in vivo. / Kim, S. A.; Moon, H.; Lee, K.; Rhee, Min-Suk.

In: Journal of Antimicrobial Chemotherapy, Vol. 70, No. 12, 01.12.2015, p. 3345-3352.

Research output: Contribution to journalArticle

Kim, S. A. ; Moon, H. ; Lee, K. ; Rhee, Min-Suk. / Bactericidal effects of triclosan in soap both in vitro and in vivo. In: Journal of Antimicrobial Chemotherapy. 2015 ; Vol. 70, No. 12. pp. 3345-3352.
@article{6bd82c5e7201402f9505345095cfb391,
title = "Bactericidal effects of triclosan in soap both in vitro and in vivo",
abstract = "OBJECTIVES: On December 2013, the US FDA proposed a rule stating that manufacturers must provide data to demonstrate that antibacterial soap is more effective than plain soap or water. The objective of the present study was to examine the in vitro and in vivo bactericidal effect of triclosan (the most widely used antiseptic agent in soap) in soap.METHODS: Twenty bacterial strains (proposed by the FDA) were exposed to plain and antibacterial soaps (the same formulation as plain soap, but containing 0.3{\%} triclosan) for 20 s at 22°C (room temperature) and 40°C (warm temperature). The temperature and time were selected to simulate the hand washing conditions and procedures used by consumers. The triclosan concentration of 0.3{\%} is the maximum allowed by law. The decontamination efficacy of plain soap and antibacterial soap was also examined in vivo: the hands of volunteers were artificially inoculated with Serratia marcescens.RESULTS: There was no significant difference (P > 0.05) in bactericidal activity between plain soap and antibacterial soap at either test temperature. However, antibacterial soap showed significantly greater bactericidal effects after 9 h. These results suggest that although triclosan-containing soap does have antibacterial activity, the effects are not apparent during the short time required for hand washing.CONCLUSIONS: Antibacterial soap containing triclosan (0.3{\%}) was no more effective than plain soap at reducing bacterial contamination when used under 'real-life' conditions. The present study provides practical information that may prove useful for both industry and governments.",
author = "Kim, {S. A.} and H. Moon and K. Lee and Min-Suk Rhee",
year = "2015",
month = "12",
day = "1",
doi = "10.1093/jac/dkv275",
language = "English",
volume = "70",
pages = "3345--3352",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Bactericidal effects of triclosan in soap both in vitro and in vivo

AU - Kim, S. A.

AU - Moon, H.

AU - Lee, K.

AU - Rhee, Min-Suk

PY - 2015/12/1

Y1 - 2015/12/1

N2 - OBJECTIVES: On December 2013, the US FDA proposed a rule stating that manufacturers must provide data to demonstrate that antibacterial soap is more effective than plain soap or water. The objective of the present study was to examine the in vitro and in vivo bactericidal effect of triclosan (the most widely used antiseptic agent in soap) in soap.METHODS: Twenty bacterial strains (proposed by the FDA) were exposed to plain and antibacterial soaps (the same formulation as plain soap, but containing 0.3% triclosan) for 20 s at 22°C (room temperature) and 40°C (warm temperature). The temperature and time were selected to simulate the hand washing conditions and procedures used by consumers. The triclosan concentration of 0.3% is the maximum allowed by law. The decontamination efficacy of plain soap and antibacterial soap was also examined in vivo: the hands of volunteers were artificially inoculated with Serratia marcescens.RESULTS: There was no significant difference (P > 0.05) in bactericidal activity between plain soap and antibacterial soap at either test temperature. However, antibacterial soap showed significantly greater bactericidal effects after 9 h. These results suggest that although triclosan-containing soap does have antibacterial activity, the effects are not apparent during the short time required for hand washing.CONCLUSIONS: Antibacterial soap containing triclosan (0.3%) was no more effective than plain soap at reducing bacterial contamination when used under 'real-life' conditions. The present study provides practical information that may prove useful for both industry and governments.

AB - OBJECTIVES: On December 2013, the US FDA proposed a rule stating that manufacturers must provide data to demonstrate that antibacterial soap is more effective than plain soap or water. The objective of the present study was to examine the in vitro and in vivo bactericidal effect of triclosan (the most widely used antiseptic agent in soap) in soap.METHODS: Twenty bacterial strains (proposed by the FDA) were exposed to plain and antibacterial soaps (the same formulation as plain soap, but containing 0.3% triclosan) for 20 s at 22°C (room temperature) and 40°C (warm temperature). The temperature and time were selected to simulate the hand washing conditions and procedures used by consumers. The triclosan concentration of 0.3% is the maximum allowed by law. The decontamination efficacy of plain soap and antibacterial soap was also examined in vivo: the hands of volunteers were artificially inoculated with Serratia marcescens.RESULTS: There was no significant difference (P > 0.05) in bactericidal activity between plain soap and antibacterial soap at either test temperature. However, antibacterial soap showed significantly greater bactericidal effects after 9 h. These results suggest that although triclosan-containing soap does have antibacterial activity, the effects are not apparent during the short time required for hand washing.CONCLUSIONS: Antibacterial soap containing triclosan (0.3%) was no more effective than plain soap at reducing bacterial contamination when used under 'real-life' conditions. The present study provides practical information that may prove useful for both industry and governments.

UR - http://www.scopus.com/inward/record.url?scp=84983494491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983494491&partnerID=8YFLogxK

U2 - 10.1093/jac/dkv275

DO - 10.1093/jac/dkv275

M3 - Article

C2 - 26374612

AN - SCOPUS:84983494491

VL - 70

SP - 3345

EP - 3352

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 12

ER -